6
56
CHEN ET AL.
6
. Geerts H. Drug evaluation: (R)-flurbiprofenan enantiomer of
flurbiprofen for the treatment of Alzheimer’s disease. IDrugs 2007; 10:
21–133.
dioctyl tartrate after ATPE, shown in Figure 10. The quantity
change of L-dioctyl tartrate before and after ATPE also
revealed the interaction of flurbiprofen enantiomers with chiral
selectors. In this study, a cutoff concentration of flurbiprofen
1
7
. Grösch S, Schilling K, Janssen A, Maier TJ, Niederberger E, Geisslinger
G. Induction of apoptosis by R-flurbiprofen in human colon carcinoma
cells: involvement of p53. Biochem Pharm 2005; 69: 831–839.
(
0.10 mmol/L) provided a separation factor of 2.34, which indi-
cated that chiral separation occurred at a concentration of
flurbiprofen that chiral selectors limited. Figure 11 illustrates
this enantioselective complexation between chiral selectors
and R- and S-enantiomers based on phenomena observed.
First, the R-enantiomer and S-enantiomer were ionized at
pH 4.0, and although flurbiprofen is hydrophobic in nature,
partition into the ATPS aqueous bottom phase was driven by
ionization. Second, L-dioctyl tartrate was added and spontane-
ously dissolved in ethanol due to the least ionization occur-
ring, whereas L-tryptophan was added and more easily
dissolved in the aqueous bottom phase due to ionization.
Third, L-dioctyl tartrate had preference in enantioselective
complexation with the R-enantiomer, providing an opportunity
of L-tryptophan forming enantioselective complexation more
with the ionized S- enantiomer. As a result, L-dioctyl tartrate
and L-tryptophan had synergistic effects on extraction of
flurbiprofen enantiomers in binary chiral recognition. This
was agreeable with our UV Vis spectral analysis in Figure 2.
8. Mahmud SM, Tanguay S, Begin LR, Franco EL, Aprikian AG. Non-steroi-
dal anti-inflammatory drug use and prostate cancer in a high-risk popula-
tion. Eur J Cancer Prev 2006; 15: 158–164.
9
. Zemskova M, Wechter W, Bashkirova S, Chen CS, Reiter R, Lilly MB.
Gene expression profiling in R-flurbiprofen-treated prostate cancer: R-
flurbiprofen regulates prostate stem cell antigen through activation of
AKT kinase. Biochem Pharm 2006; 72: 1257–1267.
1
1
1
0. Geisslinger G, Schaible HG. New insights into the site and mode of
antinociceptive action of flurbiprofen enantiomers. J Clin Pharmacol
1996; 36: 513–520.
1. Buritova J, Besson JM. Effects of flurbiprofen and its enantiomers on the
spinal c-Fos protein expression induced by noxious heat stimuli in the
anaesthetized rat. Eur J Pharm 2000; 406: 59–67.
2. Carreras I, McKee AC, Choi JK, Aytan N, Kowall NW, Jenkins BG, Dedeoglu
A. R-flurbiprofen improves tau, but not A&bgr; pathology in a triple transgenic
model of Alzheimer’s disease. Brain Res 2013; 1541: 115–127.
13. Wenda C, Haghpanah R, Rajendran A, Amanullah M. Optimization of
isocratic supercritical fluid chromatography for enantiomer separation. J
Chromatogr A 2011; 1218: 162–170.
1
4. Duan G, Ching CB. Preparative scale enantioseparation of furbiprofen by
lipase-catalysed reaction. Biochem Eng J 1998; 2: 237–245.
1
5. Lee EG, Won HS, Ro HS, Ryu YW, Chung BH. Preparation of
enantiomerically pure (S)-flurbiprofen by an esterase from Pseudomona
ssp. KCTC 10122BP. J Mol Catal B: Enzym 2003; 26: 149–156.
CONCLUSION
A novel method of chiral separation of flurbiprofen enantio-
mers, namely, BRCE-coupled ATPE, was developed based on
chiral selectors enhanced biphasic recognition in both top
and bottom phases of the ATPS used. The chiral selectors were
L-dioctyl tartrate in the top phase and L-tryptophan mainly in
the bottom phase of the ethanol / ammonium sulfate system.
It was confirmed that L-dioctyl tartrate enriched the top
phase and had preferential complexation with flurbiprofen
R-enantiomer, and L-tryptophan enriched the bottom phase
and attracted the ionized flurbiprofen S-enantiomer. The new
1
6. Patrizia S, Alessandra B, Cynthia E, Lucia G, Valerio F, Diego R,
Francesco M. Resolution of (R,S)-flurbiprofen catalysed by dry mycelia
in organic solvent. Tetrahedron 2007; 63: 11005–11010.
7. Davies NM. Methods of analysis of chiral non-steroidal anti-inflammatory
drugs. J Chromatogr B 1997; 691: 229–261.
8. Wenda C, Rajendran A. Enantioseparation of flurbiprofen on amylose-
derived chiral stationary phase by supercritical fluid chromatography. J
Chromatogr A 2009; 1216: 8750–8758.
9. Ribeiro AE, Grac NS, Pais LS, Rodrigues AE. Optimization of the mobile
phase composition for preparative chiral separation of flurbiprofen enan-
tiomers. Sep Purif Tech 2009; 68: 9–23.
0. Schuur B, Verkuij BJ, Minnaard AJ, de Vries JG, Heeres HJ, Feringa BL.
Chiral separation by enantioselective liquid-liquid extraction. Org Biomol
Chem 2011; 9: 36–51.
1. Tang KW, Yi JM, Liu YB, Jiang XY, Pan Y. Enantioselective separation of
R, S-phenylsuccinic acid by biphasic recognition chiral extraction. Chem
Eng Sci 2009; 64: 4081–4088.
1
1
1
2
2
5
0% increase in extrac-
BRCE-coupled ATPE enabled about a
tion of flurbiprofen R-enantiomer in the top phase in compari-
son with that extracted purely with ATPE. A certain cutoff
concentration of flurbiprofen was exploited in BRCE-coupled
ATPE to avoid the occurrence of nonchiral selective ATPE.
Compared to conventional enantioselective extraction, BRCE-
coupled ATPE showed a higher separation efficiency. More-
over, it is a simple, cost-effective method, which is easy to scale
up and friendly to the environment without the addition of any
organic solvent. This method could be further developed as a
potential and powerful alternative to conventional extraction
for separations of various enantiomers.
22. Tang KW, Song LT, Liu YB, Jiang XY, Pan Y. Separation of flurbiprofen
enantiomers by biphasic recognition chiral extraction. Chem Eng J
2010; 158: 411–417.
2
2
2
2
3. Tang KW, Song L, Liu YB, Miao JB. Enantioselective partitioning of 2-
phenylpropionic acid enantiomers in a biphasic recognition chiral extrac-
tion system. Chem Eng J 2012; 180: 293–298.
4. Boelo S, Marek B, Caecilia RV, Michal G, Andre BDH, Ton JV. Selector
screening for enantioseparation of DL-&agr;-methyl phenylglycine amide
by liquid-liquid extraction. Chirality 2015; 27: 123–130.
5. Peng YF, He Q, Zuo B, Niu HB, Tong TZ, Zhao HL. Enantioselective
liquid-liquid extraction of zopiclone with mandelic acid ester derivatives.
Chirality 2013; 25: 952–956.
6. David KB, Hadi MM, Vivian EF, Sayo OF, Mark L, Ioan N, Robert MS,
Isiah MW. Synthesis and characterization of novel chiral ionic liquids
and investigation of their enantiomeric recognition properties. Chirality
2008; 20: 151–158.
LITERATURE CITED
1
. Brogden RN, Heel RC, Speight TM, Avery GS. Flurbiprofen: a review of
its pharmacological properties and therapeutic use in rheumatic diseases.
Drugs 1979; 18: 417–438.
2
. Buchanan WW, Kassam YB. European experience with flurbiprofen. A
new analgesic/anti-inflammatory agent. Am J Med 1986; 80: 145–152.
3
. Gasparini L, Ongini E, Wilcock D, Morgan D. Activity of flurbiprofen and
chemically related anti-inflammatory drugs in models of Alzheimer’s dis-
ease. Brain Res Rev 2005; 48: 400–408.
27. Yi JM, Huang SJ, Jiang YR, Tang KW. Enantioselective extraction of
fenvaleric acid enantiomers by two-phase (W/O) recognition chiral ex-
traction. J Incl Phenom Macrocycl Chem 2010; 68: 271–275.
4
. Wechter WJ, Bigornia AE, Murray ED Jr, Levine BH, Young JW. Rac-
flurbiprofen is more ulcerogenic than its (S)-enantiomer. Chirality 1993;
28. Kamila S, Marcin G, Jadwiga F, Monika A. Enantioselective extraction
system containing binary chiral selectors and chromatographic
enantioseparation method for determination of the absolute configura-
tion of enantiomers of cyclopentolate. Chromatographia 2013; 76:
1603–1611.
5
: 492–494.
5
. Abdalla MM, Al-Omar MA, Al-Salahi RA, Amr AG, Sabrye NM. A new in-
vestigation for some steroidal derivatives as anti-Alzheimer agents. Int J
Biol Macromol 2012; 51: 56–63.
Chirality DOI 10.1002/chir